CoChat

Renal denervation for atrial fibrillation: a comprehensive updated systematic review and meta-analysis

Open access
Nawar, Khaled, Mohammad, Ahmed, Johns, Edward J., Abdulla, Mohammed H. · 2022 · Journal of Human Hypertension

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

The study aims to compare clinical outcomes following renal denervation (RDN) in hypertensive patients with atrial fibrillation (AF). Three online databases were searched (MEDLINE, EMBASE and PubMed) for literature related to outcomes of RDN on hypertension and AF, between January 1, 2010, and June 1, 2021. Where possible, risk ratios (RR) and mean differences (MD) were combined using a random effects model. Significance was set at p ≤ 0.05. Seven trials were included that assessed the effect of adding RDN to pulmonary vein isolation (PVI) in patients with hypertension and AF. A total of 711 patients (329 undergoing PVI + RDN and 382 undergoing PVI alone), with an age range of 56 ± 6 to 68 ± 9 years, were included. Pooled analysis showed a significant lowering of AF recurrence in the PVI + RDN (31.3%) group compared to the PVI-only (52.9%) group (p < 0.00001). Pooled analysis of patients with resistant hypertension showed a significant mean reduction of systolic blood pressure (SBP) (−9.42 mm Hg, p = 0.05), but not diastolic blood pressure (DBP) (−4.11 mm Hg, p = 0.16) in favor of PVI + RDN. Additionally, the pooled analysis showed that PVI + RDN significantly improved estimated glomerular filtration rate (eGFR) (+10.2 mL/min per 1.73 m 2, p < 0.001) compared to PVI alone. RDN procedures in these trials have proven to be both safe and efficacious with an overall complication rate of 6.32%. Combined PVI and RDN is beneficial for patients with hypertension and AF. Combined therapy showed improvement in SBP and eGFR, reducing the risk of AF recurrence. RDN may serve as an innovative intervention in the treatment of AF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41371-022-00658-0

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 PRISMA chart. Flow chart outlining the screening process for the included/excluded studies and detailing the results following each screening stage.
Fig. 1 PRISMA chart. Flow chart outlining the screening process for the included/excluded studies and detailing the results following each screening stage.CC BY · PubMed Central
Fig. 2 Effects of renal denervation on atrial fibrillation. Forest plot of the pooled comparison between PVI + RDN and PVI alone in the rate of AF recurrence of all included studies. IV inverse variance, df degrees of freedom.
Fig. 2 Effects of renal denervation on atrial fibrillation. Forest plot of the pooled comparison between PVI + RDN and PVI alone in the rate of AF recurrence of all included studies. IV inverse variance, df degrees of freedom.CC BY · PubMed Central
Fig. 3 Effects of renal denervation on blood pressure. Forest plot of pooled comparison of office BP between PVI + RDN and PVI (A) SBP (B) SBP sensitivity analysis after HFIB-1 removal (C) DBP (D) DBP sensitivity analysis after HFIB-1 removal. IV inverse variance, df degrees of freedom.
Fig. 3 Effects of renal denervation on blood pressure. Forest plot of pooled comparison of office BP between PVI + RDN and PVI (A) SBP (B) SBP sensitivity analysis after HFIB-1 removal (C) DBP (D) DBP sensitivity analysis after HFIB-1 removal. IV inverse variance, df degrees of freedom.CC BY · PubMed Central
Fig. 4 Effects of renal denervation on eGFR. Forest plot of A pooled comparison of eGFR between PVI + RDN and PVI and B sensitivity analysis after removal of Kiuchi 2017. IV inverse variance, df degrees of freedom.
Fig. 4 Effects of renal denervation on eGFR. Forest plot of A pooled comparison of eGFR between PVI + RDN and PVI and B sensitivity analysis after removal of Kiuchi 2017. IV inverse variance, df degrees of freedom.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 1

  1. Kung J, Chiappelli F, Cajulis OO, Avezova R, Kossan G, Chew L, et al. From Systematic Reviews to Clinical Recommendations for Evidence-Based Health Care: Validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for Grading of Clinical Relevance. Open Dent J. 2010;4:84–91.

Cited by

See all 34

Metadata

Authors
Nawar, K., Mohammad, A., Johns, E. J., & Abdulla, M. H.
Affiliations
University College Cork (IE)
Corresponding author
Abdulla, Mohammed H.
Venue
Journal of Human Hypertension
Published
2022-01-29
Volume
36
Issue
10
Pages
887-897
ISSN
  • 0950-9240 (ISSN-L)
  • 1476-5527
OpenAlex
W4210703310
Cited by
32
References
51
Citations by year
2026: 2 · 2025: 8 · 2024: 11 · 2023: 9 · 2022: 2
FWCI
1.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Human Hypertension (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Irish Research eLibrary
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
renal denervation, atrial fibrillation, hypertension, pulmonary vein isolation, resistant hypertension, atrial fibrillation recurrence, systolic blood pressure reduction, estimated glomerular filtration rate, procedural complications
MeSH terms
Atrial Fibrillation, Humans, Hypertension, Recurrence, Renal Artery, Sympathectomy, Treatment Outcome, Catheter Ablation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Renal denervation for atrial fibrillation: a comprehensive updated systematic review and meta-analysis. https://app.cochat.ai/papers/10.1038/s41371-022-00658-0
The paper
Nawar, K., Mohammad, A., Johns, E. J., & Abdulla, M. H. (2022). Renal denervation for atrial fibrillation: a comprehensive updated systematic review and meta-analysis. Journal of Human Hypertension. https://doi.org/10.1038/s41371-022-00658-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.